Table 1.
Study period | ||||||
---|---|---|---|---|---|---|
Screening | Procedure | 4 wk | 1 yr | 2 yr | 5 yr | |
Outpatient visit | X | X | X | X | X | |
Physical examination | X | X | X | X | X | |
Informed consent | X | |||||
Inclusion criteria | X | |||||
Randomization | X | |||||
CEAP/VCSS | X | X | X | X | X | |
Ultrasound | X | X | X | X | X | |
Pain score | X | X | ||||
AVVQ | X | X | X | X | X | |
SF-36 | X | X | X | X | X |
AVVQ, Aberdeen Varicose Vein Questionnaire; CEAP, Clinical Etiology Anatomy Pathophysiology classification; SF-36, Short Form 36-Item Health Survey; VCSS, Venous Clinical Severity Score.